Jean-Pierre Millon

Mr. Millon brings decades of experience, expertise and leadership in the healthcare and life science industries to Truvian’s board. He is currently a director at CVS Health, Inc., a role to which he was appointed in 2007 and one that has evolved as a result of the CVS merger with Caremark in April 2007 and Caremark’s purchase of AdvancePCS, a pharmacy benefit management company, in March 2004. Before his post with Caremark, Millon was named to the board of AdvancePCS in 2000 upon the merger of Advance Paradigm and PCS Health Systems. Prior to that, he was president and chief executive officer of PCS from 1996 to 2000, and also served as an executive and held several global leadership positions over the span of two decades with Eli Lilly and Company.

Millon serves on a number of healthcare company boards, including InanoBio Inc., Curemetrix, Equality Health and Valenz, and is also on the advisory boards of several companies, including Sky Republic, Kazuhm and Curematch. The latter two are incubated by Analytics Ventures, where he is also an advisor.

Millon earned a degree in mechanical engineering from Ecole Centrale de Lyon, France, and a degree in economics from the University of Lyon, France. He was awarded a Master’s of Business Administration in finance from the Kellogg School of Management at Northwestern University. He is a trustee of Scottsdale Arts and a board member of ASU Biodesign Institute.